[Recommendations of diagnosis and treatment of Takayasu's arteritis in China].

Jiang, L D; Ma, L L; Xue, Y; Pan, X; He, L; Zhao, Yan

Jiang, L D; Ma, L L; Xue, Y; Pan, X; He, L; Zhao, Yan.

Afiliación

Jiang LD; Department of Rheumatology, Zhongshan Hospital, Fudan University, Evidence-Based Medicine Center, Fudan University, Shanghai 200032, China.
Ma LL; Department of Rheumatology, Zhongshan Hospital, Fudan University, Evidence-Based Medicine Center, Fudan University, Shanghai 200032, China.
Xue Y; Department of Rheumatology, Huashan Hospital, Fudan University, Shanghai 200040, China.
Pan X; Department of Hematology and Rheumatology, First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi 832008, China.
He L; Department of Rheumatology and Immunology, First Affiliated Hospital of Xi'an JiaoTong University, Xi'an 710061, China.
Zhao Y; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases, State Key Laboratory of Complex Severe and Rare Diseases, Key Lab

Zhonghua Nei Ke Za Zhi ; 61(5): 517-524, 2022 May 01.

Article en Zh | MEDLINE | ID: mdl-35488601

Asunto(s)

Arteritis de Takayasu; China; Humanos; Prevalencia; Pronóstico; Índice de Severidad de la Enfermedad; Arteritis de Takayasu/diagnóstico; Arteritis de Takayasu/terapia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Arteritis de Takayasu Tipo de estudio: Diagnostic_studies / Guideline / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: Zh Revista: Zhonghua Nei Ke Za Zhi Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google